Clinical Trial Update: Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis [NA]

View source ↗

Summary

A completed clinical trial identified epigenetic biomarkers that may predict the severity of lung disease in cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Cystic Fibrosis | NA | Status: COMPLETED